多巴胺激动剂疗法诱导了巨型乳腺瘤中的致命肺脑病
Archana M H1, Anurag Ranjan Lila1, Manjiri Karlekar1
1Department of Endocrinology, Seth G. S. Medical College and K. E. M. Hospital, Mumbai, Maharashtra 400012, India.
JCEM case reports
|January 30, 2026
概括
用多巴胺激动剂 (DA) 治疗的巨型乳腺瘤很少会导致肺脑炎,这是一个危险的并发症. 早期识别和紧急手术对于患者在DA启动后出现头痛和意识变化等症状至关重要.
科学领域:
- 神经内分泌学神经内分泌学
- 神经外科 神经外科
- 在瘤学瘤学.
背景情况:
- 巨型前列腺瘤是巨大的垂体瘤,可导致阴性腺和头痛.
- 像卡伯戈林这样的多巴胺激动剂 (DA) 是治疗前乳腺瘤的标准治疗方法.
- 治疗DA的罕见但严重的并发症是肺脑病.
研究的目的:
- 报告一个致命的肺脑病例,该病例是在对巨型乳腺瘤进行卡贝戈林治疗后发生的.
- 审查现有的关于巨型乳腺瘤患者多巴胺激动剂诱导的肺脑病的文献.
- 强调识别和管理这种罕见并发症的重要性.
主要方法:
- 一名男性患者的病例报告,患有侵袭性巨型乳腺瘤,接受了卡伯戈林治疗.
- 对7个已发表的多巴胺激动剂诱导的肺脑病例的文献综述.
- 对临床表现,瘤特征和治疗结果的分析.
主要成果:
- 患者在开始服用卡伯戈林后出现了急性肺脑病与脑脊液鼻.
- 审查显示男性占主导地位,中位数瘤大小为5.5厘米,在DA治疗1-12周内发病.
- 报告的患者因延迟干预而死亡.
结论:
- 对巨型乳腺瘤的多巴胺激动剂治疗具有危及生命的肺脑病的风险.
- 迅速识别症状和紧急神经外科干预是至关重要的.
- 对这种罕见的并发症的认识对于临床医生来说是必不可少的,因为他们需要管理巨型乳瘤.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
880
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
880
Adrenergic Agonists: Therapeutic Uses
1.9K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.9K
Glucagon-like Receptor Agonists
954
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
954
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Adrenergic Agonists: Therapeutic Classification
1.6K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.6K


